Venus Concept Inc(VERO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -45.26 | Insider Own | 0.82% | Shs Outstand | 1.9M | Perf Week | - |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.6M | Perf Month | -74.38% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | 13.97% | Short Float | 4.48% | Perf Quarter | -33.72% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.01 | Perf Half Y | -52.5% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.07M | Perf YTD | -22.97% |
| Book/sh | - | P/C | - | EPS past 3/5Y | -0.71% - | ROE | - | 52W High | -92.14% ($14.50) | Perf Year | -71.37% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | -15.01% - | ROIC | - | 52W Low | 7.04% ($1.07) | Perf 3Y | -98.13% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 44.61% | Gross Margin | - | Volatility(W/M) | 14.54% 20.56% | Perf 5Y | -99.68% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -12.39% | Oper. Margin | - | ATR (14) | 0.67 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 44.86 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | -8.2% | SMA20 | -40.17% ($1.91) | Beta | -0.06 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2025/11/13 | SMA50 | -37.88% ($1.84) | Rel Volume | 0 | Prev Close | $1.14 |
| Employees | 292 | LT Debt/Eq | - | EPS/Sales Surpr. | -236.29% -4.88% | SMA200 | -48.74% ($2.22) | Avg Volume(3M) | 7.25M | Price | $1.14 |
| IPO | 2017/10/12 | Option/Short | No/Yes | Trades | 0 | Volume | - | Change | - |
Venus Concept (VERO) is a medical aesthetics company that designs high-frequency and laser-based energy-based devices (EBD) to supply non-invasive cosmetic treatment systems for skin tightening and body contouring, and has recently transitioned to a privately held company.
Over the past 1 year, on the lower side
92% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
Holding long would have lost money
Bought 5 years ago, your return today would be -99.7%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 14.0%.
Tap to view numbers
It ranks #140 of 144 in the industry
Based on market cap of $2M.
FAQ
What kind of company is VERO?
VERO belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of VERO?
The market cap of VERO is approximately $2M, ranking 5,806 within its sector.
What is the 52-week high and low for VERO?
VERO has recorded a 52-week high of $14.50 and a low of $1.07.
